Charles River Laboratories International (CRL) Share-based Compensation (2016 - 2025)
Charles River Laboratories International has reported Share-based Compensation over the past 17 years, most recently at $17.6 million for Q4 2025.
- Quarterly results put Share-based Compensation at $17.6 million for Q4 2025, up 2.3% from a year ago — trailing twelve months through Dec 2025 was $71.1 million (up 1.71% YoY), and the annual figure for FY2025 was $71.1 million, up 1.71%.
- Share-based Compensation for Q4 2025 was $17.6 million at Charles River Laboratories International, down from $23.3 million in the prior quarter.
- Over the last five years, Share-based Compensation for CRL hit a ceiling of $23.3 million in Q3 2025 and a floor of $13.1 million in Q1 2025.
- Median Share-based Compensation over the past 5 years was $17.2 million (2021), compared with a mean of $17.9 million.
- Biggest five-year swings in Share-based Compensation: skyrocketed 30.55% in 2021 and later decreased 21.53% in 2025.
- Charles River Laboratories International's Share-based Compensation stood at $19.2 million in 2021, then increased by 15.03% to $22.1 million in 2022, then dropped by 11.55% to $19.5 million in 2023, then dropped by 11.71% to $17.2 million in 2024, then grew by 2.3% to $17.6 million in 2025.
- The last three reported values for Share-based Compensation were $17.6 million (Q4 2025), $23.3 million (Q3 2025), and $17.0 million (Q2 2025) per Business Quant data.